Mutational analysis of the eyeless gene and phenotypic rescue reveal that an intact Eyeless protein is necessary for normal eye and brain development in Drosophila  by Clements, Jason et al.
Developmental Biology 334 (2009) 503–512
Contents lists available at ScienceDirect
Developmental Biology
j ourna l homepage: www.e lsev ie r.com/deve lopmenta lb io logyGenomes & Developmental Control
Mutational analysis of the eyeless gene and phenotypic rescue reveal that an intact
Eyeless protein is necessary for normal eye and brain development in Drosophila
Jason Clements a,b,1,2, Korneel Hens a,2,3, Srinivas Merugu b,4, Beatriz Dichtl b,5,
H. Gert de Couet c, Patrick Callaerts a,b,⁎,1
a Laboratory of Developmental Genetics, VIB, and Center of Human Genetics, Katholieke Universiteit Leuven, Herestraat 49, Box 602, B-3000, Leuven, Belgium
b Department of Biology and Biochemistry, University of Houston, Houston, TX 77204-5001, USA
c Department of Zoology, University of Hawaii at Manoa, Honolulu, HI 96822, USA⁎ Corresponding author. Laboratory of Developmenta
Human Genetics, Katholieke Universiteit Leuven, Her
Leuven, Belgium.
E-mail address: Patrick.Callaerts@med.kuleuven.be (
1 Present address: Laboratory of Developmental Gene
Genetics, Katholieke Universiteit Leuven, Herestraat 4
Belgium.
2 These authors contributed equally to this manuscrip
3 Present address: EPFL, Institute of Bioengineeri
Lausanne, Switzerland.
4 Present address: Saint Vincent Charity Hospital, 235
44115, USA.
5 Present address: Institute of Molecular Biology, U
Zürich, Switzerland.
0012-1606/$ – see front matter © 2009 Elsevier Inc. A
doi:10.1016/j.ydbio.2009.08.003a b s t r a c ta r t i c l e i n f oArticle history:
Received for publication 15 May 2009
Revised 28 July 2009
Accepted 3 August 2009







DrosophilaPax6 genes encode evolutionarily highly conserved transcription factors that are required for eye and brain
development. Despite the characterization of mutations in Pax6 homologs in a range of organisms, and
despite functional studies, it remains unclear what the relative importance is of the various parts of the Pax6
protein. To address this, we have studied the Drosophila Pax6 homolog eyeless. Speciﬁcally, we have
generated new eyeless alleles, each with single missense mutations in one of the four domains of the protein.
We show that these alleles result in abnormal eye and brain development while maintaining the OK107
eyeless GAL4 activity from which they were derived. We performed in vivo functional rescue experiments
by expressing in an eyeless-speciﬁc pattern Eyeless proteins in which either the paired domain, the
homeodomain, or the C-terminal domain was deleted. Rescue of the eye and brain phenotypes was only
observed when full-length Eyeless was expressed, while all deletion constructs failed to rescue. These data,
along with the phenotypes observed in the four newly characterized eyeless alleles, demonstrate the
requirement for an intact Eyeless protein for normal Drosophila eye and brain development. They also
suggest that some endogenous functions may be obscured in ectopic expression experiments.
© 2009 Elsevier Inc. All rights reserved.Introduction
Pax6/eyeless is involved in the development of the eye and the
brain of both invertebrates and vertebrates. In Drosophila melanoga-
ster, the Pax6 homolog eyeless is initially expressed throughout the
undifferentiated eye disc, where it persists until the cells differentiate
with the progression of the morphogenetic furrow (Halder et al.,
1998; Quiring et al., 1994). eyeless is required for normal development
of the Drosophila eye, as mutations in the eyeless gene result in
irregular facets as well as in a reduction of eye size (Lindsley andl Genetics, VIB, and Center of
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imaginal discs is able to initiate the formation of ectopic eyes (Halder
et al., 1995), establishing eyeless as a key regulator of D. melanogaster
eye development. In the vertebrate eye, Pax6 is expressed in the optic
vesicle/optic cup, lens, and cornea (Walther and Gruss, 1991) and is
required for normal development of each of these eye structures (Ton
et al., 1991; Hill et al., 1991; Grindley et al., 1995; Quinn et al., 1996).
Pax6 also has a role in retinogenesis, where it is required to maintain
the retinogenic potential of retinal progenitor cells (Marquardt et al.,
2001). Loss of Pax6 function results in aniridia or Peter's anomaly in
humans, and the small eye phenotype in the mouse and rat. Ectopic
expression of Pax6 in Xenopus laevis results in the formation of diffe-
rentiated ectopic eyes (Chow et al., 1999), highlighting the conserved
role of Pax6 during eye formation.
In the Drosophila embryonic brain, eyeless is expressed in all
three neuromeres of the brain (Kammermeier et al., 2001) while in
later stages of brain development, eyeless is primarily expressed in
the protocerebrum in e.g. the optic lobes, the mushroom bodies,
and the pars intercerebralis. Loss of eyeless activity leads to defects
in these structures (Callaerts et al., 2001; Clements et al., 2008;
Kurusu et al., 2000; Noveen et al., 2000). Vertebrate Pax6 is
involved in the development of the forebrain (Mastick et al., 1997;
Mastick and Andrews, 2001; Warren and Price, 1997), midbrain
(Matsunaga et al., 2000), and hindbrain (Osumi et al., 1997;
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roles in the patterning of neuromeres, neuronal differentiation, and
axon guidance.
The Pax6/Eyeless protein contains two DNA-binding domains,
the 128-amino acid (aa)-long paired domain containing two helix–
turn–helix (HTH) motifs (Bopp et al., 1986; Treisman et al., 1991)
and a 60-aa-long paired-like homeodomain (Frigerio et al., 1986;
Ton et al., 1991; Walther and Gruss, 1991). In addition, Pax6/Eyeless
contains a proline, serine, and threonine-rich domain at its carboxy-
terminus and a glycine-rich region of variable length that links the
amino-terminal paired domain with the more carboxy-terminal
homeodomain. A comparison of Pax6 genes from many species
revealed a high degree of structural conservation, particularly within
the two DNA-binding domains (Callaerts et al., 1997, 2006). The
high degree of sequence conservation observed in Pax6 is suggestive
of a high degree of conservation of macromolecular interactions as
well, despite the vast differences in both structure and development
of brain and eye in diverse phyla. Indeed, not only are all Pax6 genes
studied so far expressed in the brain/nerve ring and the eye/
photoreceptor, several of the target genes are conserved as well.
These include the lens crystallins, the sine oculis/Six gene family, the
eyes absent/Eya gene family, and the dachshund/Dach gene family
(Callaerts et al., 1997, 2006; Wawersik and Maas, 2000; see Gehring
and Ikeo, 1999; van Heyningen and Williamson, 2002; Kozmik, 2008
for further reviews on Pax6).
The high degree of sequence conservation argues for conserved
functions for the DNA binding paired and homeodomains, as well as
the transactivating C-terminal domain. Pax6 has effectively three
DNA-binding HTH domains: the amino-terminal (PAI) and carboxy-
terminal (RED) subdomains of the paired domain and the home-
odomain. By using multiple combinations of DNA binding domains,
Pax proteins potentially regulate a multitude of different functions
(Jun and Desplan, 1996). This hypothesis is supported by data in
which a missense mutation in the paired domain can either abolish
or increase the DNA binding and transcription dependent on
homeodomain binding sites (Singh et al., 2000). Furthermore, point
mutations in the transactivation domain can reduce or abolish the
DNA-binding activity of the paired domain or the homeodomain
(Singh et al., 2001). The activity of the transactivation domain
requires the entire domain (152-aa in human) for maximal activity
(Tang et al., 1998). These data suggest a requirement of the paired
domain, homeodomain, and transactivation domain for Pax6 func-
tion. However, given the high degree of conservation and its known
DNA binding roles, surprisingly few homeodomain mutations have
been found in comparison to the many paired domain and
transactivation domain mutations, suggesting that the homeodomain
may not be necessary for Pax6 function. Indeed, in Drosophila, the
eyeless phenotype in the eye was rescued in 79% of cases by an
Eyeless protein lacking the homeodomain, which was also able to
induce the formation of ectopic eyes (Punzo et al., 2001). In contrast,
the characterization of missense mutations affecting only the
homeodomain of Pax6 (Azuma et al., 2003; Favor et al., 2001;
Morrison et al., 2002; Redeker et al., 2008; Thaung et al., 2002)
suggests that the homeodomain is required for normal function.
Here we describe a requirement for the paired domain, the
linker region, the homeodomain, and the C-terminal domain of the
D. melanogaster Pax6 homolog eyeless during eye and brain
development. Furthermore, we demonstrate that the C-terminal
domain of Eyeless functions as a transactivation domain as in Pax6.
We describe four new eyeless alleles created by mutagenesis of the
eyeless Gal4 driver OK107. This Gal4 driver expresses the yeast
transcriptional activator Gal4 in an eyeless pattern in the Drosophila
eye and brain (Adachi et al., 2003), allowing the targeted expression
of any gene or construct that is preceded by the Gal4 upstream
activating sequence (UAS) in cells that normally express eyeless
(Brand and Perrimon, 1993). The four new alleles of eyeless alsomaintained the Gal4 activity of OK107, and thus allowed us to
attempt rescue of the eye and brain phenotypes of homozygous
mutant animals by driving the expression of Eyeless deletion
constructs in an eyeless expression pattern. We describe, for the
ﬁrst time, complete rescue of the eyeless phenotype with full-length
Eyeless protein. On the other hand, deletion of the paired domain,
the homeodomain, or the C-terminal domain of the Eyeless protein
resulted in the failure of these proteins to rescue either the eye or
the brain phenotype of homozygous eyeless mutants. The new
alleles are each caused by a single missense mutation in one of the
four major domains of the Eyeless protein, resulting in abnormal
eye and brain development. These data, along with the rescue
experiments, strongly suggest that an Eyeless protein with each
domain intact is necessary for normal Eyeless function. In addition,
in one of the alleles, eyOK107/6, Eyeless protein failed to localize to
the nucleus, revealing a nuclear localization signal (NLS) in the
recognition helix of the homeodomain.
Materials and methods
Mutagenesis screen
In order to generate eyeless alleles on the OK107 chromosome, we
mutagenized 1500 homozygous OK107 males with 35 mM EMS as
described (Lewis and Bacher, 1968; see Supplemental Fig. 1 for
mutagenesis scheme). These males were then crossed en masse to ciD
females in order to obtain OK107⁎/ciD males (asterisk indicates
mutagenized chromosome). 3314 males of this genotype were
crossed individually to eyD1Da/cilacZ females. The progeny of this
cross consisted of four possible genotypes (OK107⁎/eyD1Da, OK107⁎/
cilacZ, eyD1Da/ciD, and cilacZ/ciD, which is lethal). Flies without the ciD
phenotype were then screened for the eyeless phenotype (eyes
reduced or lost), identifying multiple independent putative alleles. Of
these, non-ciD ﬂies without an eyeless phenotype (presumed
genotype: OK107⁎/cilacZ) were crossed to eyD1Da/ciD ﬂies in order to
(1) verify the phenotype and (2) establish the eyOK107/X/ciD stocks
(the name eyOK107/X refers to the entire series of alleles generated in
this screen).
Analysis of phenotypes
The eye was examined by comparing the size of each mutant
eye to the eye of a wildtype (Oregon-R) animal. Mutant eyes were
then assigned to one of the following categories: 75–100% (eye
relatively normal in size), 50–75%, 25–50%, 1–25% (eye present but
extremely small, usually less than 50 ommatidia), or no eye (eye
completely absent). Brain phenotypes were gauged on the basis of
the morphology of the mushroom bodies and the central complex,
both of which are dependent on eyeless for normal development.
This was determined by whole-mount staining of adult brains with
the monoclonal antibody 1D4. Brain defects were assigned to one
of the following categories: no defects (structure phenotypically
wildtype), mild (a few, subtle defects observed), severe (signiﬁcant
disorganization of neuropil structure), or very severe (structure
completely or nearly completely absent).
Fly stocks
Flies were maintained at 25°C on standard agar-cornmeal-
molasses medium. Fly stocks or alleles used were OK107 (Connolly
et al., 1996), eyD1Da and eyJD (Callaerts et al., 2001), eyEH
(Benassayag et al., 2003), ey2 (available from the Bloomington
Stock Center), Pabp2CC00380 (Buszczak et al., 2007), and cilacZ (from
Thomas Kornberg). Fly stocks used for rescue of the eyeless
phenotype were UAS-ey (Halder et al., 1995) and UAS-eyΔPD,
UAS-eyΔHD, and UAS-eyΔCTD (Punzo et al., 2001).
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Whole-mount immunostaining with antibodies against Eyeless,
Fasciclin II, or GFP was performed on D. melanogaster adult brains
or larval brain-imaginal disc complexes. These were dissected in
PBS, ﬁxed for 15 min in 4% formaldehyde in PBS, followed by three
10-min washes in PBS and preincubation in PAXD solution (PBS
containing 5% BSA, 0.3% Triton X-100, and 0.3% sodium deoxycho-
late) for at least 10 min. Incubations in primary and secondary
antibodies were performed overnight at 4°C and followed by
extensive washing in PAXD solution at room temperature. The
primary antibodies were a rat polyclonal antibody against the
Eyeless linker region (1:500 dilution), a rabbit polyclonal antibody
against GFP (1:500 dilution; Invitrogen, Eugene, OR), and the
monoclonal antibodies 1D4 against FasII (1:20 dilution; Develop-
mental Studies Hybridoma Bank) and A11H6 against Eyeless (1:10
dilution; Clements et al., 2008). The secondary antibodies were
FITC- or Cy3-conjugated (1:200 dilution; Jackson ImmunoResearch
Laboratories, West Grove, PA). Brains or dissected imaginal discs
were mounted in Vectashield mounting medium for ﬂuorescence
(Vector Laboratories, Burlingame, CA) and stored at 4°C. Observa-
tions were made on an Olympus AX70 microscope equipped for
epiﬂuorescence and images were collected using a Magnaﬁre digital
camera. Some images were generated using a Leica TCS SP2 laser
confocal microscope.
Adult head preparations
Adult ﬂy heads were dissected and placed in 70% ethanol and
stored at 4°C for several hours to several days, then mounted in
Hoyer's medium and incubated at 50°C to make the cuticle more
transparent (Sullivan et al., 2000).
Molecular characterization of eyeless alleles
The characterization of the eyOK107/X alleles was performed as
described by Callaerts et al. (2001) with the following modiﬁcations.
Exons of eyeless were PCR-ampliﬁed with either Pwo polymerase or
Tgo polymerase (Roche Molecular Biochemicals, Indianapolis, IN)Table 1
Genetic complementation analysis.
Genotype Total eyes % Wild type eye size
0 1-25 25
[OK107/4]×[JD] 10 3 1 3
[OK107/4]×[D1Da] 46 7 4 11
[OK107/4]×[OK107/10] 76 0 3 0
[OK107/4]×[2] 100 0 0 0
[OK107/10]×[JD] 54 2 0 2
[OK107/10]×[D1Da] 68 0 0 10
[OK107/10]×[2] 132 0 0 0
[OK107/6]×[JD] 48 6 2 9
[OK107/6]×[D1Da] 70 2 0 7
[OK107/6]×[OK107/4] 52 0 4 15
[OK107/6]×[OK107/10] 104 0 0 0
[OK107/6]×[2] 110 0 0 0
[OK107/16]×[JD] 46 0 0 14
[OK107/16]×[D1Da] 28 2 7 14
[OK107/16]×[OK107/4] 22 2 2 13
[OK107/16]×[OK107/6] 90 1 6 23
[OK107/16]×[OK107/10] 34 0 3 8
[OK107/16]×[2] 114 0 0 7
“Total eyes” shows the total number of eyes that were scored to obtain the percentages di
indicated eye size, ranging from 0% wild type eye size (i.e. no eye) to 1–25%, 25–50%, 50–75
from no defects (−) over mild (+), severe (++) to very severe (+++). The severity was d
for mushroom bodies (MB), and the level of disorganization of the central complex (CC
transheterozygous progeny of the genotype eyOK107/4/eyJD.and subcloned into the TOPO TA cloning vector (Invitrogen,
Carlsbad, CA) for sequencing. Sequencing was done as a service by
Seqwright (Houston, TX).
Analysis of transactivation by the Eyeless C-terminal domain
in cell culture
Plasmids
The possible role of the C-terminal domain (CTD) of Eyeless in
transactivation was studied by transient cotransfection experiments
in Drosophila Schneider-2 culture cells. Hybrid cDNAs encoding
fusion proteins of the GAL4 DNA-binding domain and the wildtype or
eyD1Da mutant version of the CTD of Eyeless were cloned under a
metallothionein promoter in the pRmHa3 plasmid (Wisniewski et al.,
1996). A hybrid protein of the GAL4 DNA-binding domain with the
viral VP16 transactivating domain was used as a positive control
(Wisniewski et al., 1996). The reporter plasmids consist of the
Upstream Activating Sequences to which GAL4 can bind, a minimal
promoter and the ﬁreﬂy luciferase reporter gene taken from the pGL2
luciferase vector (Promega™ Madison, WI). The efﬁciency of the
cotransfection experiments was normalized by cotransfecting the
Renilla luciferase reporter gene under the control of a promotor that
is constitutively active in S2 cells (actin promotor).
Transfection
The procedure consisted of the following steps: (1) Schneider S2
cells were cultured in Schneider's medium containing 10% Fetal
Bovine Serum and grown to late log phase. (2) Conﬂuent cells were
harvested and plated in 60 mm Petri dishes at 5×106 cells/ml. (3)
10 μg of each plasmid was mixed with FuGENE transfection reagent
(Roche Molecular Biochemicals) and incubated with the cells for
30 min. (4) The supernatant was removed, new medium added, and
the cells were allowed to recover for 48 h. (5) Cells were harvested
with cell scrapers and the luciferase assays were performed
according to the manufacturer's protocol (Promega). Each transfec-
tion assay was done ﬁve times and statistical signiﬁcance was
determined using Duncan's test.MB defects CC defects
-50 50-75 75-100
2 1 +++ +++
14 10 +++ ++
8 65 +++ +
0 100 − −
1 49 ++ −
49 9 +++ +
1 131 − −
18 13 +++ ++
54 7 +++ +
30 3 +++ ++
9 95 ++ +
0 110 − −
25 7 ++ +++
5 0 +++ ++
5 0 ++ +++
54 6 ++ ++
18 5 ++ +
42 65 − −
splayed. The numbers in the different categories refer to the number of eyes with the
%, and 75–100%. Brain defects were ranked according to degree of disruption and range
etermined by analyzing the frequency of the lobes missing or lobes reduced phenotype
). The genotypes are listed by subscripts. For example [OK107/4]x[JD] refers to the
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Fireﬂy and Renilla luciferase activity was determined with the
Dual-Luciferase Reporter Assay System (Promega) and measured
with a Packard Top Count NXT luminometer.
Results
Isolation of new eyeless alleles by EMS mutagenesis of the OK107
Gal4 enhancer trap
Eyeless encodes a transcription factor with two DNA binding
domains, the paired domain and the homeodomain, and a PST-rich
carboxy-terminal domain (Quiring et al., 1994). We sought to
determine which domains were required for normal development
of the eye and the brain, and which, if any, were dispensable.
Ideally, these experiments would be done using the endogenous
regulatory sequences of eyeless. The Gal4 driver line OK107
(Connolly et al., 1996), an enhancer trap line with a P-element
insertion 6.5 kb upstream of the ﬁrst exon of eyeless, drives Gal4
expression in an eyeless-speciﬁc pattern in the eye and brainFig. 1. (A) Schematic representation of the predicted protein products encoded by wild type
this paper), eyD1Da and eyJD (Callaerts et al., 2001) and eyEH and ey11 (Benassayag et al., 200
region (LR), the homeodomain (HD, grey shading), and the C-terminal domain (CTD). (B)
staining reveals α, β, and γ lobes of the mushroom bodies. One of the frequently observed p
previously documented in Callaerts et al. (2001). Size bars are 25 μm.(Adachi et al., 2003), thus making it an ideal driver for our studies.
However, while this Gal4 line does exhibit developmental defects in
the mushroom body lobes in approximately 50% of homozygous
animals (results not shown) the eye and remaining brain structures
are phenotypically wildtype, as the defects are likely caused by a
disruption of a mushroom body enhancer near the P-element
insertion site (Adachi et al. 2003). Since OK107 Gal4 does not have
any eye defects, nor does it result in brain defects when in trans to
other eyeless alleles, we mutagenized OK107 in order to generate
mutations affecting the Eyeless protein itself while maintaining the
Gal4 activity of the driver. We isolated four new eyeless alleles
(eyOK107/4, eyOK107/6, eyOK107/10, and eyOK107/16: collectively referred
to here as the eyOK107/X alleles) by their failure to complement the
known allele eyD1Da. Once identiﬁed, a complementation analysis
was carried out with the alleles eyD1Da, eyJD, and ey2 to assess the
severity of the new alleles (Table 1). The eyOK107/X alleles failed to
complement, and signiﬁcant eye and brain defects were observed in
almost all transheterozygous allelic combinations. Phenotypes were
most severe in eyOK107/4 and eyOK107/16, while the phenotypes
observed in eyOK107/10 ﬂies were the mildest of the eyOK107/X alleles.
Eye and brain development was not signiﬁcantly affected in eithereyeless, the four eyOK107/X alleles (stars indicate position of the amino acid substitution;
3). The Eyeless protein consists of the paired domain (PRD, black shading), the linker
Head and eye defects in homozygous eyOK107/X mutants. (C) Anti-Fasciclin II antibody
henotypes is the loss of lobes (marked with arrowheads in the different panels) as was
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previous observations for eyJD/ey2 and eyD1Da/ey2 (Callaerts et al.,
2001). However, the eyOK107/16/ey2 combination exhibited a mod-
erate eye phenotype. All allelic combinations not involving ey2
resulted in signiﬁcant eye and brain defects of differing magnitude.
All eyOK107/X alleles displayed severe mushroom body and central
complex phenotypes in all combinations (except with ey2). The
observed central complex defect, but not the mushroom body
defect, was markedly less severe in combinations involving the
eyOK107/10 allele.
The new eyOK107/X alleles encode missense mutations in the
Eyeless protein
eyeless encodes a transcription factor comprised of an amino-
terminal paired domain, a glycine-rich linker region, a paired-like
homeodomain, and a carboxy-terminal domain. To date, all charac-
terized eyeless alleles encode either truncated proteins (eyD1Da, eyJD,
ey11, eyEH; Benassayag et al., 2003; Callaerts et al., 2001) are protein
null (eyJ5.71 and presumably eyC7.20; Kammermeier et al., 2001; Punzo
et al., 2001) or affect eyeless expression by disruption of intronic
enhancer elements (ey2 and eyR; Quiring et al., 1994). In contrast, the
four new eyeless alleles represent single amino acid substitutions in
each of the four major domains of Eyeless protein (Fig. 1A). The allele
eyOK107/4 is caused by a transition in which cytosine 993 in exon 5 is
replaced with thymine, resulting in the P302L substitution in the
linker region (nucleotide and amino acid numbering system as used
by Quiring et al., 1994). The allele eyOK107/6 encodes a missense
mutation in position 12 of the recognition helix of the homeodomain
(R463Q) as a result of a guanine to adenine transition in nucleotide
position 1476 of exon 7. The allele eyOK107/10 affects the carboxy-
terminal domain of the protein causing the mutation S831F, as
encoded by a transition mutation in nucleotide 2580 in exon 9 in
which cytosine is replaced with thymine. The fourth allele, eyOK107/16,
is also a cytosine to thymine transition, affecting nucleotide 390 of
exon 4 and results in the missense mutation P101L in the carboxy-
terminal tail of the paired domain. None of the eyOK107/X mutations
affect protein synthesis or stability of the Eyeless protein (Fig. S2).
All four eyOK107/X alleles cause abnormal development of the eye
and brain (Figs. 1B and C). The eyes in the mutant are signiﬁcantly
reduced, although there is signiﬁcant variability between mutant
animals as well as between the two eyes of the same animal, as is
typical for eyeless alleles. In the brain, organization of major
neuropils such as the mushroom bodies, the central complex, andTable 2
Phenotypic rescue experiments using the UAS-GAL4 system to express variants of the Eyel
Genotype Total eyes % Wild type eye size
0 1–25 2
[EH]/[OK107/16] 92 29 15 2
UE10;[EH]/[OK107/16] 62 0 0
UAS-ΔPD;[EH]/[OK107/16] 62 8 18 2
UAS-ΔHD;[EH]/[OK107/16] 46 0 4
UAS-ΔCTD;[EH]/[OK107/16] 68 4 19 2
[JD]/[OK107/16] 90 2 10 1
UE10;[JD]/[OK107/16] 96 0 0
UAS-ΔPD;[JD]/[OK107/16] 50 0 0
UAS-ΔHD;[JD]/[OK107/16] 64 0 3
UAS-ΔCTD;[JD]/[OK107/16] 44 1 6 1
The ranking of phenotypes was done as in Table 1. “Total eyes” shows the total number of e
categories refer to the number of eyes with the indicated eye size, ranging from 0%wild type
according to degree of disruption and range from no defects (−) over mild (+), severe (++
lobes missing or lobes reduced phenotype for mushroom bodies (MB), and the level of disorg
are listed by subscripts. Other abbreviations: UE10: UAS-Eyeless full length; UASΔPD: UAS-
UAS-Eyeless minus C-terminal domain.the pars intercerebralis is severely disrupted. Interestingly, one
allele, eyOK107/6, is homozygous viable despite its apparent brain
defects, a phenomenon atypical of eyeless alleles.
In summary, these data conﬁrm the previously established
importance of the paired domain and the C-terminal domain, while
revealing the functional importance of both the linker region and the
homeodomain in eye and brain development.
All domains of the Eyeless protein are essential for normal development
The newly isolated alleles allowed us to study the requirement
for the various domains of Eyeless by driving the expression of
eyeless cDNA deletion constructs in a homozygous eyeless mutant
background using the Gal4 system (Brand and Perrimon, 1993). The
ability of the deletion constructs to rescue the eye and/or brain
phenotypes typical of eyeless mutants would therefore be expected
to reveal the relative contribution of these domains for development
of these structures. Speciﬁcally, we expressed deletion constructs
encoding proteins in which either the paired domain (eyΔPD), the
homeodomain (eyΔHD), or the C-terminal domain (eyΔCTD) was
deleted from the protein (Punzo et al., 2001) in a transheterozygous
eyeless mutant background using the allele eyOK107/16. The constructs
ey (full-length), eyΔPD and eyΔHD, were previously shown to give
comparable expression levels (Punzo et al., 2001). We conﬁrmed
this by Western blotting and quantitation and extended the
observations to eyΔCTD, with the deletion constructs maximally
expressed at about twofold the level of the full-length (results not
shown). While we found that truncated Eyeless proteins did provide
some degree of rescue when compared to homozygous mutants,
only expression of the intact Eyeless protein resulted in complete
rescue of the eyeless phenotype (Table 2 and Fig. 2). In the eye,
deletion of the paired domain or the carboxy-terminal domain only
provided a negligible amount of rescue in which no more than 10%
of eyes are larger than 50% of wildtype size. In contrast, deletion of
the homeodomain led to a greater degree of rescue, in which the
majority of eyes were larger than 50% of wildtype size, although this
value was still signiﬁcantly lower than that observed for the
complete Eyeless protein. In the brain, rescue of both the mushroom
body and central complex phenotypes was attained only with the
full-length Eyeless UAS construct, with the exception of the home-
odomain deletion construct, which rescued the brain phenotype in
an eyOK107/16/eyJD mutant background, but not in an eyOK107/16/eyEH
background. All other Eyeless deletion constructs did not provide
any signiﬁcant degree of rescue.ess protein.
MB defects CC defects
5–-50 50–75 75–100
0 16 10 +++ ++
0 0 62 +/− +/−
5 10 1 +++ +++
9 14 19 ++ ++
2 22 1 +++ ++
4 37 27 +++ ++
0 3 97 +/− −
1 3 46 +++ ++
5 15 41 +/− −
0 24 3 +++ ++
yes that were scored to obtain the percentages displayed. The numbers in the different
eye size (i.e. no eye) to 1–25%, 25–50%, 50–75%, and 75–100%. Brain defects were ranked
) to very severe (+++). The severity was determined by analyzing the frequency of the
anization of the central complex (CC). As in Table 1, the genotypes of the eyeless alleles
Eyeless minus paired domain; UASΔHD UAS-Eyeless minus homeodomain; UASΔCTD:
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Consistent with its role as a transcription factor, three potential
nuclear localization signals have been identiﬁed in Pax6 (Carrière
et al., 1995; Glaser et al., 1995), although the requirement of any
one particular NLS is unclear. The ﬁrst of these is located within the
paired domain, as isoforms lacking this region of the protein are
localized predominantly in the cytoplasm (Carrière et al., 1995). The
second putative NLS is found at the amino-terminus of the
homeodomain, and is similar to the SV40 T-antigen NLS (Glaser
et al., 1995). Although a missense mutation affecting this NLS has
been identiﬁed in a patient with aniridia (Hanson et al., 1993),
there is some debate whether this mutation affects nuclear
localization (Carrière et al., 1995; Glaser et al., 1995). Lastly, there
is a third putative NLS at the carboxy-terminus of the homeodomain
(Glaser et al., 1995). All three putative NLSs are also conserved in
Eyeless. The identiﬁcation of the missense mutation (Arg to Gln)
in the eyOK107/6 allele demonstrates the functionality of the
carboxy-terminal NLS. In this mutant, Eyeless protein is abundant
in the cytoplasm as well as the nucleus, contrary to the exclusive
nuclear localization of wildtype Eyeless protein (Fig. 3 and
Fig. S2). This demonstrates a functional requirement of this NLS
for proper localization of Eyeless protein to the nucleus. InFig. 2. The eye, head, and brain phenotypes observed in homozygous eyeless ﬂies can be re
Gal4 activity present in the eyOK107/16mutant. Eyeless UAS constructs in which one domain o
mutant background (see Table 2 for complete results). (A–D) Anti-Fasciclin II antibody stain
(marked as an outline where the lobe is expected to be) and the phenotypic rescue with
phenotypes in wild type control (E) and in the eyOK107/16 mutant in the presence of differen
rescues the eye and head phenotypes (F) whereas an Eyeless transgene encoding an Eyeless p
balancer chromosome (H) and yields ﬂies with head and eye (arrowhead) defects and no phe
the same row (e.g. I represents the genotype of the animals shown in A and E).addition, the observation that some protein is localized to the
nucleus in eyOK107/6 mutants suggests the existence of at least one
other functional NLS within the Eyeless protein.
The carboxy-terminus of Eyeless is required for transactivation
Given that the PST-rich C-terminal domains of mammalian and
sea urchin Pax6 function as transactivation domains (Czerny and
Busslinger, 1995; Glaser et al., 1994), and that truncations in the
Eyeless C-terminal domain are associated with mutant phenotypes
(Benassayag et al., 2003; Callaerts et al., 2001), we sought to deter-
mine if the PST-rich C-terminal domain of Eyeless also demonstrated
transactivation activity. Transient transfection experiments with
plasmids encoding fusion proteins of the GAL4 DNA-binding domain
with variants of the Eyeless C-terminal domain, and luciferase
reporter genes, revealed that the Eyeless C-terminal domain potently
induces transcription of reporter genes to approximately 35% of
GAL4-VP16-induced transcription levels (Fig. 4). Relative transcrip-
tion was reduced to negative control levels (GAL4-DNA binding
domain-only) when the mutation associated with the eyD1Da allele
was introduced in the C-terminal domain. In the eyD1Da allele, a
premature stop codon results in the loss of the most C-terminal 30%
of the PST-rich domain (Callaerts et al., 2001), suggesting that thescued only by full-length Eyeless (UE10=UAS full-length Eyeless) when driven by the
f the Eyeless protein has been removed do not result in a phenotypic rescue in the same
ing reveals α, β, and γ lobes of the mushroom bodies. Note the lack of lobes in C and D
presence of normal mushroom lobes in B. Size bars are 25 μm. (E–H) Head and eye
t UAS-Eyeless rescue constructs. Note that expression of full-length Eyeless completely
rotein without the C-terminal domain (G) is not different from the siblings carrying the
notypic rescue. (I–L) Genotypes of the animals displayed in the corresponding panels on
Fig. 3. Abnormal subcellular localization of protein encoded by the allele eyOK107/6. (A–C) Eyeless localizes to the nucleus in wild type eye discs. Single channel image of wildtype eye
discs in a heterozygous Pabp2CC00380 background, which ubiquitously expresses a nuclear-localized Pabp2–GFP fusion protein, stained with Eyeless (A) or GFP (B). (C) Overlay of
Eyeless (magenta) and GFP (green) reveals nuclear colocalization of Pabp2–GFP and Eyeless. (D–F) Eyeless is primarily cytoplasmic in eyOK107/6 mutant eye discs. Single channel
image stained with Eyeless (D) or GFP (E). (F) Overlay of Eyeless (magenta) and GFP (green) reveals limited overlap between Pabp2–GFP and Eyeless and thus cytoplasmic
localization of mutant Eyeless protein. Size bars are 5 μm.
509J. Clements et al. / Developmental Biology 334 (2009) 503–512PST-rich C-terminus and in particular its most C-terminal portion is
a key determinant for transactivation by Eyeless.
Discussion
Since the original identiﬁcation of Pax6 and its association with
defective eye development inmouse, human, andDrosophila (Walther
and Gruss, 1991; Hill et al., 1991; Ton et al., 1991; Quiring et al., 1994),
complementary approaches have been used to gain insight into the
mechanistic basis of Pax6 function in eye and brain development. The
identiﬁcation of mutations in human PAX6 (current number of 494
entries in LOVD (https://lsdb.hgu.mrc.ac.uk/home.php), ofwhich 299
are unique) underscores the importance of all parts of the PAX6
protein. Contrary to this, it has been shown that truncated versions of
the Drosophila Pax6 homolog Eyeless are able to induce ectopic eyes
and also display a considerable capacity to rescue eyeless mutant
phenotypes (Punzo et al., 2001). We addressed this apparentFig. 4. The C-terminal domain of Eyeless functions as a transcriptional activator.
Luciferase activity relative to pRmGVP16 for four protein fusions with the GAL4 DNA-
binding domain. pRmG: empty vector negative control encoding the GAL4 DNA-binding
domain only. pRmGEy: Eyeless C-terminal domain fusion. pRmGEy-D1Da: Eyeless C-
terminal domain fusion with the eyD1Da mutation. pRmGVP16: fusion with the strong
transactivation domain of Herpes simplex VP16 as positive control. pRmGEy is
signiﬁcantly different from pRmGEy-D1Da and pRmG (p=0.0001, Duncan test).discrepancy by a mutational analysis of eyeless and in vivo rescue
experiments using variants of eyeless encoding proteins that lack
distinct protein domains. Our results reveal that only an intact protein
provides all properties for full function when rescue experiments are
conducted using endogenous regulatory sequences of the eyeless gene.
Furthermore, we provide novel insight into the in vivo role of each
domain. Lastly, our data suggest that endogenous functions of genes
may be obscured in ectopic or overexpression experiments.
In vivo structure–function analysis reveals new features of the
Eyeless protein
Paired Domain
The paired domain is a 128-aa DNA-binding motif characteristic of
the Pax family of proteins. The paired domain consists of two HTH
motifs, the N-terminal PAI domain and the C-terminal RED domain
(Jun and Desplan, 1996), which are joined by a 16-aa extended
linker. Unlike the D. melanogaster Paired paired domain (Xu et al.,
1995), both the PAI and the RED domains of the Pax6 paired domain
make major groove contacts with DNA, although the contacts via the
N-terminal subdomain are more numerous and of greater afﬁnity
(Xu et al., 1999). However, the Pax6a isoform, which has a fourteen
amino acid insertion into the N-terminal domain, binds solely
through the C-terminal RED domain (Epstein et al., 1994; Kozmik
et al., 1997; Walther and Gruss, 1991). Furthermore, cooperative
interactions of the paired domain with other DNA-binding domains
such as the homeodomain and the Ets domain have been demon-
strated (Fitzsimmons et al., 1996; Jun and Desplan, 1996; Sheng et al.,
1997; Underhill et al., 1995; Underhill and Gros, 1997). Lastly, single
missense mutations affecting the paired domain can lead to the loss
or strengthening of homeodomain binding or it can inﬂuence the
transactivation that normally follows DNA-binding (Fortin et al.,
1997; Singh et al., 2000). Together, these data show that DNA-
binding by the paired domain is context-dependent, and that it
inﬂuences the activity of other parts of the protein, i.e. DNA binding
by the homeodomain or transactivation.
We describe here the isolation of an allele of eyeless (eyOK107/16)
that results in the substitution of proline 65 (Pro65) with a leucine in
510 J. Clements et al. / Developmental Biology 334 (2009) 503–512the paired domain linker region. The crystal structure of the Pax6
paired domain complexed to DNA reveals that the extended linker
that connects the PAI and RED subdomains makes numerous contacts
with bases and the sugar phosphate backbone. Pro65 makes van der
Waals contacts with the phosphate backbone of the minor groove of
the DNA and also interacts with Arg16 in the β2 turn unit of the N-
terminal domain (Xu et al., 1999). The proline that is substituted in
the eyOK107/16 allele is conserved in all Pax proteins (Walther et al.,
1991), suggesting that it is crucial for normal paired domain linker
function. Indeed, a patient with bilateral morning glory disc anomaly
was identiﬁed in which a missense mutation in the homologous
amino acid (P68S) was found (Azuma et al., 2003). It is likely that the
P65L substitution of eyOK107/16 results in a major conformational
alteration as a result of the bulkier Leu sidechain, and consequently
affects the ability of the paired domain linker to interact with the
minor groove of its target by disrupting the van der Waals contacts
with the phosphate backbone or by destabilizing β-turn docking with
the DNA. In accordance with this prediction, human Pax6 protein in
which the P68S mutation was introduced showed a severe impair-
ment in its ability to activate reporter gene expression in a
chloramphenicol acetyltransferase assay (Azuma et al., 2003). A
direct role for the paired domain linker region in target site selection
and DNA binding has also been shown in Pax3 (Vogan et al., 1996;
Vogan and Gros, 1997).
Linker
The linker is a glycine-rich region of variable length that joins
the paired domain and the homeodomain. Invertebrate Pax6 linkers
are usually longer than those found in vertebrate species, such as
the D. melanogaster Eyeless linker that is three times as long as the
78-aa mouse and human Pax6 linker, for example (Callaerts et al.,
1997, 2006). The linker of Pax6 does not contain the octapeptide
that is found in the majority of Pax family members. However, there
is a highly conserved undecapeptide which is usually found near the
C-terminus of the paired domain, as well as a string of twelve
conserved amino acids that precedes the N-terminus of the
homeodomain (Callaerts et al., 1997, 2006). Although the conser-
vation of these regions implies a structural or functional role, the
exact function of the linker remains elusive. We have identiﬁed a
missense mutation in the linker region of the eyeless gene in the
eyOK107/4 allele, which results in severe eye defects, as well as
extreme mushroom body and central complex defects. The only
other missense mutation in the Pax6 linker was described by Azuma
et al. (1998), and resulted in bilateral total aniridia in a 35-year-old
woman and her 6-year-old son, demonstrating a functional require-
ment for the linker in humans. Combined, these data demonstrate
that the Pax6 linker region is functionally important. Thus far, the
only documented role for the linker region concerns Pax3, in which
the linker is important for the interaction of the paired domain and
homeodomain (Fortin et al., 1998).
Homeodomain
Pax6/Eyeless contains a 60-aa-long paired-like homeodomain. The
homeodomain is a DNA-binding domain, consisting of an N-terminal
armand threeα-helices,whichhas a critical role in the development of
higher eukaryotes (Scott et al., 1989). Helix 2 and helix 3 of the
homeodomain form a helix–turn–helix motif, in which the third helix
(the recognition helix) ﬁts into the major groove of the DNA, while
Helix 2 holds it in position by laying across it (Laughon and Scott,
1984). Two amino acids of the recognition helix contact DNA directly,
whereas the remaining amino acids of Helix 3 interact with the DNA
indirectly via contact with water molecules that in turn interact with
the nucleotides of the major groove (Billeter et al., 1993;Wilson et al.,
1995). The amino acid at position 50 of the homeodomain is crucial in
determining DNA-binding speciﬁcity since substitution of the amino
acid at this position results in an alteration of binding site recognition(Treisman et al., 1989). Arg-2 and Arg-5 of the N-terminal arm of the
homeodomain interact directly with the core of the recognition motif,
the tetranucleotide TAAT, suggesting that this arm has an important
role in sequence recognition as well (Wilson et al., 1995). It has been
shown for the protein encoded by the D. melanogaster gene paired
(Wilson et al., 1993) and for mouse and sea urchin Pax6 (Czerny and
Busslinger, 1995) that the paired class homeodomains bind DNA as
cooperative dimers on so-called P3 sites. The latter are palindromic
sequences consisting of two inverted TAAT half sites separated by
three nucleotides (Wilson et al., 1993). This binding occurs via the N-
terminal arm of each homeodomain interacting with Helix 2 of the
other (Wilson et al., 1995).
The allele eyOK107/6, which results in the substitution of an
arginine for a glutamine at position 12 of the recognition helix, for
the ﬁrst time reveals several important features of the Eyeless
homeodomain. Arginine 12 forms salt bridges with the DNA back-
bone of the major groove (Billeter et al., 1993), and is conserved in
paired class homeodomains, and in most other classes of home-
odomains (Treisman et al., 1992; Wilson et al., 1995). It is likely that
loss of this salt bridge destabilizes the interaction between the
recognition helix and the major groove, resulting in reduced afﬁnity
for the recognition site.
Interestingly, the arginine–glutamine substitution found in
eyOK107/6 also disrupts the function of a required nuclear localization
signal, resulting in Eyeless protein that is found in both the nucleus
and cytoplasm. Unlike vertebrates to Pax6, Drosophila heterozygous
for an eyeless mutation do not generally exhibit any obvious
phenotypes. Therefore it seems probable that the developmental
defects observed in eyOK107/6 mutants are due to an impaired ability
of the homeodomain to bind DNA, and not due to an inadequate
level of nuclear Eyeless protein.
C-terminal transactivation domain
We have demonstrated previously the importance of the C-
terminus of Eyeless, as the alleles eyD1Da and ey11, which encode
proteins with truncated C-termini, display severe developmental
defects (Benassayag et al., 2003; Callaerts et al., 2001). The location of
a transactivation domain in the PST-rich C-terminus of Pax6 in human
(Glaser et al., 1994), mouse, and sea urchin (Czerny and Busslinger,
1995) was previously demonstrated. By means of transient transfec-
tion experiments we show that the Eyeless C-terminal domain is a
transactivation domain. The loss of transactivation following the
introduction of the eyD1Da mutation in the C-terminal domain
identiﬁes the C-terminal 156 amino acids as critical for this function.
Finally, we have characterized a new allele of eyeless, eyOK107/10,
which results in the substitution of a serine for a phenylalanine in the
C-terminus of the Eyeless protein located eight amino acids from the
carboxyterminal end of the protein. Like the other eyOK107/X alleles,
eyOK107/10 exhibits both eye and brain developmental defects,
although the phenotypes are milder than those caused by the other
eyOK107/X alleles. The eyOK107/10 allele appears to be very sensitive to
genetic background, as an observable eye phenotype in homozygous
mutant animals is lost after only a few generations. This suggests that
the functional effects of this mutation are easily overcome by other
gene products in the D. melanogaster proteome. Since this mutation is
located in the C-terminal domain of Eyeless, it is conceivable that the
substitution has an effect on transactivation. However, by analogy to a
missensemutation described for the human PAX6 C-terminal domain,
it is also possible that the substitution in Eyeless negativelymodulates
DNA-binding by the homeodomain (Singh et al., 2001).
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